Cardiac care in trisomy 18: A path to improved outcomes (case report)

Abdullghany Dowaikh1, Atif Alsahari2, Saad Khoshhal3

  • 1Pediatric Cardiology Department, Prince Sultan Cardiac Center, Riyadh, Kingdom of Saudi Arabia.

Insights

Cardiac interventions may benefit infants with Trisomy 18 (Edwards syndrome), despite associated developmental anomalies. This case shows positive outcomes from pulmonary valvuloplasty and PDA stenting, suggesting individualized treatment is viable.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatrics

Background:

  • Trisomy 18 (Edwards syndrome) is a genetic disorder with severe developmental issues.
  • Cardiac complications are a primary cause of mortality in Trisomy 18 patients.
  • The efficacy of cardiac interventions in this population is debated.

Observation:

  • A full-term infant diagnosed with Trisomy 18 presented with pulmonary atresia and other cardiac defects.
  • The neonate underwent emergency procedures including balloon pulmonary valvuloplasty and patent ductus arteriosus (PDA) stenting.
  • The infant experienced a transient desaturation post-intervention but ultimately showed positive response.

Findings:

  • Successful cardiac intervention in a Trisomy 18 patient with complex congenital heart disease.
  • Demonstrated feasibility of pulmonary valvuloplasty and PDA stenting in this demographic.
  • Positive patient response suggests potential for improved outcomes.

Implications:

  • Challenges the assumption that cardiac interventions are universally unsuitable for Trisomy 18.
  • Highlights the potential for selective cardiac interventions to improve quality of life.
  • Supports the need for further research and individualized treatment guidelines for Trisomy 18 patients with cardiac conditions.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
485
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
461